ArticleEye (London, England)2026
Optical coherence tomography imaging device comparison study in papilloedema secondary to idiopathic intracranial hypertension.
Article in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOptic nerve imaging assessing papilloedema is an increasingly important clinical measure to guide treatment. The aim of this study was to understand the agreement between two commonly used OCT devices and whether pooling of papilloedema OCT imaging data could be easily facilitated.
methodsPeople living with idiopathic intracranial hypertension (IIH) underwent non-dilated same-day OCT imaging performed on Spectralis SD-OCT (Heidelberg Engineering, Heidelberg, Germany) and Cirrus 6000 OCT (Carl Zeiss Meditec, Dublin, CA). Comparable measurements were collected (retinal nerve fibre layer (RNFL), maximum height of the optic nerve head and macular ganglion cell layer assessment). Bland-Altman plots were constructed, intraclass correlation coefficient (ICC) and Pearson correlation coefficient were calculated.
resultsNinety-seven people with a definite diagnosis of IIH were included: 95% were women with a mean age of 31 years. Mean global RNFL thickness was 117.4μm (SD 41.6) on the Spectralis platform and 122.5μm (SD 53.8) on the Cirrus platform. There was excellent agreement between the devices for RNFL thickness measurements (ICC = 0.922), although the Bland-Altman plot revealed increasing discrepancy at higher RNFL thicknesses. Maximum disc height displayed good agreement (ICC = 0.882) between devices. There was a very strong positive correlation between Spectralis GCL volume and Cirrus GC-IPL thickness(r = 0.911).
conclusionsThis OCT imaging dataset spanning a range of papilloedema severity in people with a definite diagnosis of IIH showed good relative agreement of RNFL measurements between Spectralis and Cirrus devices at RNFL thicknesses close to normal, but greater variance with more severe papilloedema. RNFL measurements from the two devices cannot be used interchangeably. Macular GCL assessments showed a strong positive linear correlation.
Identifiers
42773248What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.